Global Medical Linear Accelerator Market – Industry Trends and Forecast to 2029

Medical Linear Accelerator Market Analysis and Size

The market for medical linear is expected to grow in the forecast period. The demand for medical linear accelerators in the region is driven by high awareness, the presence of a large pool of the patient population, a high penetration rate, better product availability, and extensive reach of innovative products. The same is also further reinforced by a well-connected distribution network.

Data Bridge Market Research analyses that the medical linear accelerator market which was USD 3178.45 million in 2021, would rocket up to USD 5502.13 million by 2029, and is expected to undergo a CAGR of 7.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Medical Linear Accelerator Market Scope and Segmentation

Market Definition

A high-energy X-ray device called the medical linear accelerator (LINAC) uses high-energy photons to treat deep tumours. Medical LINACs use a tuned cavity waveguide, where radio frequency (RF) power creates a standing wave, to accelerate electrons. For cancer patients receiving external beam radiation therapy, this equipment is most frequently utilised. It releases high-energy electrons or X-rays that are directed at the tumor-affected region.

Medical Linear Accelerator Market Dynamics

Drivers

• Rising cancer cases

The increasing incidence of cancer in the world, along with quick technology breakthroughs and rising healthcare costs, is anticipated to fuel market expansion. Due to its efficiency, linear accelerators (LINAC) are regarded as ground-breaking medical technology that has transformed treatment.

• Rising cancer patients

The market has experienced tremendous expansion in sales volume, particularly as cancer is becoming more common and a greater need for non-invasive cancer treatments. Due to altered lifestyles, an ageing population, environmental pollutants, and an increase in smokers, the prevalence of cancer is rising alarmingly on a global scale. One of the main reasons for the high mortality rate in the world is this.

Opportunities

• Artificial Intelligence Innovations

The market for medical imaging devices is being completely transformed by artificial intelligence. Artificial intelligence (AI) and machine learning (ML) innovations are rapidly changing LINAC-based cancer treatment. Vendors are concentrating on creating LINACs for oncology therapy that are AI and ML enabled as a result, and these devices are expected to become practical therapeutic choices in the future years.

Restraints/Challenges

• High cost

On the other hand, the high cost associated with treatment has led to an increase in the number of patients opting for radiation therapy as a treatment option will obstruct the market's growth rate. 

This medical linear accelerator market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medical linear accelerator market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In April 2021, the rising worldwide cancer burden, Varian, a Siemens Healthineers company, has a contract with Australia's Icon Group to offer 30 linear accelerators and related treatment software. Together, Varian and Icon Group will increase access to care in remote and underserved areas of Australia and Asia by further solidifying their worldwide alliance.
• In June 2020, Teledyne e2v US, a division of Teledyne Digital Imaging US, Inc., named RS&A Inc., an independent service provider of medical equipment with headquarters throughout the United States, as its distributor of its linear accelerator medical and industrial products in the Americas.

Global Medical Linear Accelerator Market Scope

The medical linear accelerator market is segmented on the basis of product type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product type

•  Low-energy
•  High-energy

End users

•  Hospitals
• Clinics
•  Research Institute
•  Medical Schools

Medical Linear Accelerator Market Regional Analysis/Insights

The medical linear accelerator market is analysed and market size insights and trends are provided by country, product type and end-user as referenced above.

The countries covered in the medical linear accelerator market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the medical linear accelerator market due to the growing preference for technologically advanced medical LINAC devices.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing prevalence of cancer in Europe. Breast, colorectum, lung, prostate and bladder cancers were the region's most common cancer cases in 2018.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The medical linear accelerator market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for medical linear accelerator market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medical linear accelerator market. The data is available for historic period 2010-2020.

Competitive Landscape and Medical Linear Accelerator Market Share Analysis

The medical linear accelerator market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to medical linear accelerator market.

Some of the major players operating in the medical linear accelerator market are:

• Varian Medical Systems Inc. (U.K.)
• Elekta (Sweden)
• Accuray, Incorporated (U.S.)
• Hitachi Ltd. (Japan)
• Shinva Medical Instrument Co. Ltd. (China)
• Mitsubishi Heavy Industries, Ltd. (Japan)
• Huiheng Medical, Inc. (China)
• Top Grade Healthcare (India)
• General Electric (U.S.)
• Koninklijke Philips N.V. (Netherlands)

SKU-69039